Exploring breast tissue microbial composition and the association with breast cancer risk factors.
Acetobacter aceti
Breast cancer risk factors
Lactobacillus
Normal breast
Ralstonia
Xanthomonas sp.
Journal
Breast cancer research : BCR
ISSN: 1465-542X
Titre abrégé: Breast Cancer Res
Pays: England
ID NLM: 100927353
Informations de publication
Date de publication:
10 07 2023
10 07 2023
Historique:
received:
16
02
2023
accepted:
20
06
2023
medline:
12
7
2023
pubmed:
11
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Microbial dysbiosis has emerged as an important element in the development and progression of various cancers, including breast cancer. However, the microbial composition of the breast from healthy individuals, even relative to risk of developing breast cancer, remains unclear. Here, we performed a comprehensive analysis of the microbiota of the normal breast tissue, which was analyzed in relation to the microbial composition of the tumor and adjacent normal tissue. The study cohorts included 403 cancer-free women (who donated normal breast tissue cores) and 76 breast cancer patients (who donated tumor and/or adjacent normal tissue samples). Microbiome profiling was obtained by sequencing the nine hypervariable regions of the 16S rRNA gene (V1V2, V2V3, V3V4, V4V5, V5V7, and V7V9). Transcriptome analysis was also performed on 190 normal breast tissue samples. Breast cancer risk score was assessed using the Tyrer-Cuzick risk model. The V1V2 amplicon sequencing resulted more suitable for the analysis of the normal breast microbiome and identified Lactobacillaceae (Firmicutes phylum), Acetobacterraceae, and Xanthomonadaceae (both Proteobacteria phylum) as the most abundant families in the normal breast. However, Ralstonia (Proteobacteria phylum) was more abundant in both breast tumors and histologically normal tissues adjacent to malignant tumors. We also conducted a correlation analysis between the microbiome and known breast cancer risk factors. Abundances of the bacterial taxa Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp. were associated with age (p < 0.0001), racial background (p < 0.0001), and parity (p < 0.0001). Finally, transcriptome analysis of normal breast tissues showed an enrichment in metabolism- and immune-related genes in the tissues with abundant Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp., whereas the presence of Ralstonia in the normal tissue was linked to dysregulation of genes involved in the carbohydrate metabolic pathway. This study defines the microbial features of normal breast tissue, thus providing a basis to understand cancer-related dysbiosis. Moreover, the findings reveal that lifestyle factors can significantly affect the normal breast microbial composition.
Sections du résumé
BACKGROUND
Microbial dysbiosis has emerged as an important element in the development and progression of various cancers, including breast cancer. However, the microbial composition of the breast from healthy individuals, even relative to risk of developing breast cancer, remains unclear. Here, we performed a comprehensive analysis of the microbiota of the normal breast tissue, which was analyzed in relation to the microbial composition of the tumor and adjacent normal tissue.
METHODS
The study cohorts included 403 cancer-free women (who donated normal breast tissue cores) and 76 breast cancer patients (who donated tumor and/or adjacent normal tissue samples). Microbiome profiling was obtained by sequencing the nine hypervariable regions of the 16S rRNA gene (V1V2, V2V3, V3V4, V4V5, V5V7, and V7V9). Transcriptome analysis was also performed on 190 normal breast tissue samples. Breast cancer risk score was assessed using the Tyrer-Cuzick risk model.
RESULTS
The V1V2 amplicon sequencing resulted more suitable for the analysis of the normal breast microbiome and identified Lactobacillaceae (Firmicutes phylum), Acetobacterraceae, and Xanthomonadaceae (both Proteobacteria phylum) as the most abundant families in the normal breast. However, Ralstonia (Proteobacteria phylum) was more abundant in both breast tumors and histologically normal tissues adjacent to malignant tumors. We also conducted a correlation analysis between the microbiome and known breast cancer risk factors. Abundances of the bacterial taxa Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp. were associated with age (p < 0.0001), racial background (p < 0.0001), and parity (p < 0.0001). Finally, transcriptome analysis of normal breast tissues showed an enrichment in metabolism- and immune-related genes in the tissues with abundant Acetotobacter aceti, Lactobacillus vini, Lactobacillus paracasei, and Xanthonomas sp., whereas the presence of Ralstonia in the normal tissue was linked to dysregulation of genes involved in the carbohydrate metabolic pathway.
CONCLUSIONS
This study defines the microbial features of normal breast tissue, thus providing a basis to understand cancer-related dysbiosis. Moreover, the findings reveal that lifestyle factors can significantly affect the normal breast microbial composition.
Identifiants
pubmed: 37430354
doi: 10.1186/s13058-023-01677-6
pii: 10.1186/s13058-023-01677-6
pmc: PMC10332106
doi:
Substances chimiques
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
82Informations de copyright
© 2023. The Author(s).
Références
Nat Commun. 2016 Jan 29;7:10478
pubmed: 26823093
mBio. 2014 Sep 16;5(5):e01714-14
pubmed: 25227467
J Oncol. 2021 Jan 22;2021:4035257
pubmed: 33552156
Sci Rep. 2015 Oct 15;5:15162
pubmed: 26469225
Cells. 2019 Mar 29;8(4):
pubmed: 30934972
Trends Microbiol. 2019 Feb;27(2):105-117
pubmed: 30497919
Appl Environ Microbiol. 2014 May;80(10):3007-14
pubmed: 24610844
BMC Cancer. 2022 Jan 3;22(1):30
pubmed: 34980006
Breast Cancer (Dove Med Press). 2021 Apr 13;13:241-257
pubmed: 33883932
Microbiome. 2017 Jan 25;5(1):9
pubmed: 28118849
Nat Med. 2018 Oct;24(10):1526-1531
pubmed: 30150717
Proceedings (IEEE Int Conf Bioinformatics Biomed). 2011 Feb 4;2010:153-157
pubmed: 22102981
PLoS One. 2014 Jan 08;9(1):e83744
pubmed: 24421902
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Sci Rep. 2019 Aug 16;9(1):11940
pubmed: 31420578
Int Immunopharmacol. 2012 Dec;14(4):729-33
pubmed: 23102661
Genome Med. 2021 Apr 16;13(1):60
pubmed: 33863341
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Clin Microbiol Infect. 2013 Apr;19(4):305-13
pubmed: 23452229
mSystems. 2019 Nov 26;4(6):
pubmed: 31771977
Front Microbiol. 2019 Jun 25;10:1378
pubmed: 31293535
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Genome Biol. 2014;15(12):550
pubmed: 25516281
Epigenetics. 2020 Oct;15(10):1093-1106
pubmed: 32255732
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
Sci Rep. 2018 Jun 27;8(1):9749
pubmed: 29950689
Environ Microbiol Rep. 2016 Jun;8(3):399-406
pubmed: 27043715
Metabolites. 2021 Nov 04;11(11):
pubmed: 34822416
Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19537-42
pubmed: 24218583
Cancer Discov. 2021 May;11(5):1138-1157
pubmed: 33408241
Sci Rep. 2016 Aug 03;6:30751
pubmed: 27485780
Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):958-974
pubmed: 29655782
Clin Epigenetics. 2022 Feb 9;14(1):21
pubmed: 35139887
Appl Environ Microbiol. 2016 Jul 29;82(16):5039-48
pubmed: 27342554
Sci Rep. 2019 Feb 4;9(1):1300
pubmed: 30718646
Microbiome. 2018 Dec 17;6(1):226
pubmed: 30558668
Pediatr Gastroenterol Hepatol Nutr. 2022 May;25(3):194-210
pubmed: 35611376
Cells. 2019 Dec 15;8(12):
pubmed: 31847455
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
J Biol Chem. 2019 Dec 6;294(49):18586-18599
pubmed: 31636122
Front Oncol. 2020 Feb 12;10:120
pubmed: 32117767
NPJ Breast Cancer. 2020 Oct 6;6:50
pubmed: 33083529
Curr Protoc. 2021 Mar;1(3):e90
pubmed: 33780170
Commun Biol. 2021 Oct 27;4(1):1229
pubmed: 34707244
BMJ. 2000 Sep 9;321(7261):624-8
pubmed: 10977847
Sci Rep. 2018 Nov 15;8(1):16893
pubmed: 30442969
Breast Cancer Res Treat. 2009 Nov;118(2):229-39
pubmed: 19685287
Cells. 2020 Apr 28;9(5):
pubmed: 32354130
Breast Cancer Res Treat. 2012 May;133(1):169-77
pubmed: 21881938
Cancer Metab. 2016 Apr 01;4:6
pubmed: 27042297
mSystems. 2022 Jun 28;7(3):e0148921
pubmed: 35642922
J Dent Res Dent Clin Dent Prospects. 2017 Fall;11(4):208-214
pubmed: 29354246
Nat Commun. 2019 Nov 6;10(1):5029
pubmed: 31695033
Appl Environ Microbiol. 2014 Jan;80(2):788-96
pubmed: 24242251
Breast Cancer Res Treat. 2014 Jan;143(1):57-68
pubmed: 24292813
PeerJ. 2016 Oct 18;4:e2584
pubmed: 27781170
Cell Death Dis. 2021 Sep 4;12(9):831
pubmed: 34482363
BMC Microbiol. 2013 Sep 14;13:208
pubmed: 24034943
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Sci Rep. 2020 Aug 24;10(1):14116
pubmed: 32839514
Nat Commun. 2017 Oct 20;8(1):1077
pubmed: 29057876
NPJ Breast Cancer. 2023 Jan 26;9(1):4
pubmed: 36702853
J Immunol. 2014 Apr 15;192(8):3805-15
pubmed: 24646734
Aesthet Surg J. 2018 May 15;38(suppl_2):S52-S61
pubmed: 29240873
Life (Basel). 2022 Jan 02;12(1):
pubmed: 35054452
Microorganisms. 2020 Aug 25;8(9):
pubmed: 32854338
Int J Mol Sci. 2021 Aug 22;22(16):
pubmed: 34445764
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4539-46
pubmed: 20615998
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460